Clinical Trial Update: Prevention of Coronavirus Disease (COVID-19) Outbreaks With Nitazoxanide [Phase 4]

View source ↗

Summary

Phase 4 trial update on nitazoxanide for preventing COVID-19 outbreaks; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Infection

Drugs mentioned

• Nitazoxanide (nitazoxanide)

Snippet

Sponsor: Materno-Perinatal Hospital of the State of Mexico | Conditions: Coronavirus Infection | Phase 4 | Status: COMPLETED